Cargando…

Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues

Ubiquitylation is a covalent post-translational modification that regulates protein stability and is involved in many biological functions. Proteins may be modified with mono-ubiquitin or ubiquitin chains. Viruses have evolved multiple mechanisms to perturb the cell ubiquitin system and manipulate i...

Descripción completa

Detalles Bibliográficos
Autores principales: Maluquer de Motes, Carlos, Schiffner, Torben, Sumner, Rebecca P., Smith, Geoffrey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for General Microbiology 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135091/
https://www.ncbi.nlm.nih.gov/pubmed/24914067
http://dx.doi.org/10.1099/vir.0.065664-0
_version_ 1782330935613587456
author Maluquer de Motes, Carlos
Schiffner, Torben
Sumner, Rebecca P.
Smith, Geoffrey L.
author_facet Maluquer de Motes, Carlos
Schiffner, Torben
Sumner, Rebecca P.
Smith, Geoffrey L.
author_sort Maluquer de Motes, Carlos
collection PubMed
description Ubiquitylation is a covalent post-translational modification that regulates protein stability and is involved in many biological functions. Proteins may be modified with mono-ubiquitin or ubiquitin chains. Viruses have evolved multiple mechanisms to perturb the cell ubiquitin system and manipulate it to their own benefit. Here, we report ubiquitylation of vaccinia virus (VACV) protein N1. N1 is an inhibitor of the nuclear factor NF-κB and apoptosis that contributes to virulence, has a Bcl-2-like fold, and is highly conserved amongst orthopoxviruses. The interaction between N1 and ubiquitin occurs at endogenous protein levels during VACV infection and following ectopic expression of N1. Biochemical analysis demonstrated that N1 is covalently ubiquitylated, and heterodimers of ubiquitylated and non-ubiquitylated N1 monomers were identified, suggesting that ubiquitylation does not inhibit N1 dimerization. Studies with other VACV Bcl-2 proteins, such as C6 or B14, revealed that although these proteins also interact with ubiquitin, these interactions are non-covalent. Finally, mutagenesis of N1 showed that ubiquitylation occurs in a conventional lysine-dependent manner at multiple acceptor sites because only an N1 allele devoid of lysine residues remained unmodified. Taken together, we described a previously uncharacterized modification of the VACV protein N1 that provided a new layer of complexity to the biology of this virulence factor, and provided another example of the intricate interplay between poxviruses and the host ubiquitin system.
format Online
Article
Text
id pubmed-4135091
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Society for General Microbiology
record_format MEDLINE/PubMed
spelling pubmed-41350912014-09-01 Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues Maluquer de Motes, Carlos Schiffner, Torben Sumner, Rebecca P. Smith, Geoffrey L. J Gen Virol Animal Ubiquitylation is a covalent post-translational modification that regulates protein stability and is involved in many biological functions. Proteins may be modified with mono-ubiquitin or ubiquitin chains. Viruses have evolved multiple mechanisms to perturb the cell ubiquitin system and manipulate it to their own benefit. Here, we report ubiquitylation of vaccinia virus (VACV) protein N1. N1 is an inhibitor of the nuclear factor NF-κB and apoptosis that contributes to virulence, has a Bcl-2-like fold, and is highly conserved amongst orthopoxviruses. The interaction between N1 and ubiquitin occurs at endogenous protein levels during VACV infection and following ectopic expression of N1. Biochemical analysis demonstrated that N1 is covalently ubiquitylated, and heterodimers of ubiquitylated and non-ubiquitylated N1 monomers were identified, suggesting that ubiquitylation does not inhibit N1 dimerization. Studies with other VACV Bcl-2 proteins, such as C6 or B14, revealed that although these proteins also interact with ubiquitin, these interactions are non-covalent. Finally, mutagenesis of N1 showed that ubiquitylation occurs in a conventional lysine-dependent manner at multiple acceptor sites because only an N1 allele devoid of lysine residues remained unmodified. Taken together, we described a previously uncharacterized modification of the VACV protein N1 that provided a new layer of complexity to the biology of this virulence factor, and provided another example of the intricate interplay between poxviruses and the host ubiquitin system. Society for General Microbiology 2014-09 /pmc/articles/PMC4135091/ /pubmed/24914067 http://dx.doi.org/10.1099/vir.0.065664-0 Text en © 2014 The Authors http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Animal
Maluquer de Motes, Carlos
Schiffner, Torben
Sumner, Rebecca P.
Smith, Geoffrey L.
Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues
title Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues
title_full Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues
title_fullStr Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues
title_full_unstemmed Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues
title_short Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues
title_sort vaccinia virus virulence factor n1 can be ubiquitylated on multiple lysine residues
topic Animal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135091/
https://www.ncbi.nlm.nih.gov/pubmed/24914067
http://dx.doi.org/10.1099/vir.0.065664-0
work_keys_str_mv AT maluquerdemotescarlos vacciniavirusvirulencefactorn1canbeubiquitylatedonmultiplelysineresidues
AT schiffnertorben vacciniavirusvirulencefactorn1canbeubiquitylatedonmultiplelysineresidues
AT sumnerrebeccap vacciniavirusvirulencefactorn1canbeubiquitylatedonmultiplelysineresidues
AT smithgeoffreyl vacciniavirusvirulencefactorn1canbeubiquitylatedonmultiplelysineresidues